OxyContin Will Face Fewer Generics Following Patent Infringement Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
As part of settlement agreements with Purdue Pharma, Endo and Teva agree to stop selling generic versions of the pain medication.